ETC Awarded $17.3 Million Contract for its Sterilization Systems Group 30-06-2023, 03:47

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

NEBRASKA WOMAN GETS SHOCK OF A LIFETIME AS PRIZE PATROL 2-03-2023, 08:14